Zhou, Wei
Chen, Min-min
Liu, Hui-ling
Si, Zi-lin
Wu, Wen-hui
Jiang, Hong
Wang, Lin-xiao
Vaziri, Nosratola D.
An, Xiao-fei
Su, Ke
Chen, Cheng
Tan, Ning-hua
Zhang, Zhi-hao
Article History
Received: 18 December 2021
Accepted: 6 March 2022
First Online: 28 March 2022
Competing interests
: The authors declare no competing interests.
: The studies involving human participants were reviewed and approved by the medical ethics committee of the Affiliated Hospital of Nanjing University of Chinese Medicine and followed the tenets of the Declaration of Helsinki (2019NL-109-02). The studies involving animal experiments were reviewed and approved by the institutional ethics committee for animal experimentation of China Pharmaceutical University and the application approval number was 202002001.
: Written consents from participants were also acquired.